Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
European Radiology
Published in: European Radiology 5/2014

01-05-2014 | Pediatric

Whole-body MRI for initial staging of paediatric lymphoma: prospective comparison to an FDG-PET/CT-based reference standard

Authors: Annemieke S. Littooij, Thomas C. Kwee, Ignasi Barber, Claudio Granata, Malou A. Vermoolen, Goya Enríquez, József Zsíros, Shui Yen Soh, Bart de Keizer, Frederik J. A. Beek, Monique G. Hobbelink, Marc B. Bierings, Jaap Stoker, Rutger A.J. Nievelstein

Published in: European Radiology | Issue 5/2014

Login to get access

Abstract

Objective

To compare whole-body MRI, including diffusion-weighted imaging (whole-body MRI-DWI), with FDG-PET/CT for staging newly diagnosed paediatric lymphoma.

Methods

A total of 36 children with newly diagnosed lymphoma prospectively underwent both whole-body MRI-DWI and FDG-PET/CT. Whole-body MRI-DWI was successfully performed in 33 patients (mean age 13.9 years). Whole-body MRI-DWI was independently evaluated by two blinded observers. After consensus reading, an unblinded expert panel evaluated the discrepant findings between whole-body MRI-DWI and FDG-PET/CT and used bone marrow biopsy, other imaging data and clinical information to derive an FDG-PET/CT-based reference standard.

Results

Interobserver agreement of whole-body MRI-DWI was good [all nodal sites together (κ = 0.79); all extranodal sites together (κ = 0.69)]. There was very good agreement between the consensus whole-body MRI-DWI- and FDG-PET/CT-based reference standard for nodal (κ = 0.91) and extranodal (κ = 0.94) staging. The sensitivity and specificity of consensus whole-body MRI-DWI were 93 % and 98 % for nodal staging and 89 % and 100 % for extranodal staging, respectively. Following removal of MRI reader errors, the disease stage according to whole-body MRI-DWI agreed with the reference standard in 28 of 33 patients.

Conclusions

Our results indicate that whole-body MRI-DWI is feasible for staging paediatric lymphoma and could potentially serve as a good radiation-free alternative to FDG-PET/CT.

Keypoints

• Accurate staging is important for treatment planning and assessing prognosis
• Whole-body MRI-DWI could be a good radiation-free alternative to FDG-PET/CT
• Interobserver agreement of whole-body MRI-DWI is good
• Agreement between whole-body MRI and the FDG-PET/CT reference standard is good
• Most discrepancies were caused by suboptimal accuracy of size measurements on MRI
Literature
1.
Li J, Thompson TD, Miller JW, Pollack LA, Stewart SL (2008) Cancer incidence among children and adolescents in the United States, 2001–2003. Pediatr 121:e1470–e1477CrossRef
2.
3.
Ansell SM, Armitage J (2005) Non-Hodgkin lymphoma: diagnosis and treatment. Mayo Clin Proc 80:1087–1097PubMedCrossRef
4.
Lister TA, Crowther D, Sutcliffe SB (1989) Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. J Clin Oncol 7:1630–1636PubMed
5.
Murphy SB (1980) Classification, staging and end results of treatment of childhood non-Hodgkin's lymphomas: dissimilarities from lymphomas in adults. Semin Oncol 7:332–339PubMed
6.
7.
la Fougère C, Hundt W, Bröckel N et al (2006) Value of PET/CT versus PET and CT performed as separate investigations in patients with Hodgkin’s disease and non-Hodgkin’s lymphoma. Eur J Nucl Med Mol Imaging 33:1417–1425PubMedCrossRef
8.
Juweid ME, Stroobants S, Hoekstra OS et al (2007) Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma. J Clin Oncol 25:571–578PubMedCrossRef
9.
Brenner D, Elliston C, Hall E, Berdon W (2001) Estimated risks of radiation-induced fatal cancer from pediatric CT. AJR Am J Roentgenol 176:289–229PubMedCrossRef
10.
11.
Kwee TC, van Ufford HM, Beek FJ et al (2009) Whole-body MRI, including diffusion-weighted imaging, for the initial staging of malignant lymphoma: comparison to computed tomography. Invest Radiol 44:683–690PubMedCrossRef
12.
van Ufford HM, Kwee TC, Beek FJ et al (2011) Newly diagnosed lymphoma: initial results with whole-body T1-weighted, STIR, and diffusion-weighted MRI compared with 18 F-FDG PET/CT. AJR Am J Roentgenol 196:662–669PubMedCrossRef
13.
Lin C, Luciani A, Itti E et al (2010) Whole-body diffusion-weighted magnetic resonance imaging with apparent diffusion coefficient mapping for staging patients with diffuse large B-cell lymphoma. Eur Radiol 20:2027–2038PubMedCrossRef
14.
Gu J, Chan T, Zhang J, Leung AY, Kwong YL, Khong PL (2011) Whole-body diffusion-weighted imaging: the added value to whole-body MRI at initial diagnosis of lymphoma. AJR Am J Roentgenol 197:W384–W391PubMedCrossRef
15.
Brennan DD, Gleeson T, Coate LE, Cronin C, Carney D, Eustace SJ (2005) A comparison of whole-body MRI and CT for the staging of lymphoma. AJR Am J Roentgenol 185:711–716PubMedCrossRef
16.
Punwani S, Taylor SA, Bainbridge A et al (2010) Pediatric and adolescent lymphoma: comparison of whole-body STIR half-Fourier RARE MR imaging with an enhanced PET/CT reference for initial staging. Radiology 255:182–190PubMedCrossRef
17.
Kellenberger CJ, Miller SF, Khan M, Gilday DL, Weitzman S, Babyn PS (2004) Initial experience with FSE STIR whole-body MR imaging for staging lymphoma in children. Eur Radiol 14:1829–1841PubMedCrossRef
18.
Delbeke D, Coleman RE, Guiberteau MJ et al (2006) Procedure guideline for tumor imaging with 18 F-FDG PET/CT 1.0. J Nucl Med 47:885–895PubMed
19.
Lassmann M, Biassoni L, Monsieurs M, Franzius C, EANM Dosimetry Paediatrics Committees (2008) The new EANM paediatric dosage card: additional notes with respect to F-18. Eur J Nucl Med Mol Imaging 35:1666–1668PubMedCrossRef
20.
King AD, Ahuja AT, Yeung DK et al (2007) Malignant cervical lymphadenopathy: diagnostic accuracy of diffusion-weighted MR imaging. Radiology 245:806–813PubMedCrossRef
21.
Wang J, Takashima S, Takayama F et al (2001) Head and neck lesions: characterization with diffusion-weighted echo-planar MR imaging. Radiology 220:621–630PubMedCrossRef
22.
Vermoolen MA, Kwee TC, Nievelstein RA (2012) Apparent diffusion coefficient measurements in the differentiation between benign and malignant lesions: a systematic review. Insights Imaging 3:395–409PubMedCentralPubMedCrossRef
23.
Kwee TC, Takahara T, Luijten PR, Nievelstein RA (2010) ADC measurements of lymph nodes: inter- and intra-observer reproducibility study and an overview of the literature. Eur J Radiol 75:215–220PubMedCrossRef
24.
Lin C, Itti E, Luciani A et al (2011) Whole-body diffusion-weighted imaging with apparent diffusion coefficient mapping for treatment response assessment in patients with diffuse large B-cell lymphoma: pilot study. Invest Radiol 46:341–349PubMed
25.
Haddy TB, Parker RI, Magrath IT (1989) Bone marrow involvement in young patients with non-Hodgkin's lymphoma: the importance of multiple bone marrow samples for accurate staging. Med Pediatr Oncol 17:418–423PubMedCrossRef
26.
Ribrag V, Vanel D, Leboulleux S et al (2008) Prospective study of bone marrow infiltration in aggressive lymphoma by three independent methods: whole-body MRI, PET/CT and bone marrow biopsy. Eur J Radiol 66:325–331PubMedCrossRef
27.
Adams HJ, Kwee TC, Vermoolen MA (2013) Whole-body MRI for the detection of bone marrow involvement in lymphoma: prospective study in 116 patients and comparison with FDG-PET. Eur Radiol 23:2271–2278PubMedCrossRef
28.
Kwee TC, Nievelstein RA (2011) Is MRI less accurate than FDG-PET/CT in diagnosing bone marrow involvement in lymphoma? Eur J Radiol 80:565–566PubMedCrossRef
29.
El-Galaly TC, d’Amore F, Mylam KJ et al (2012) Routine bone marrow biopsy has little or no therapeutic consequence for positron emission tomography/computed tomography-staged treatment-naive patients with Hodgkin lymphoma. J Clin Oncol 30:4508–4514PubMedCrossRef
30.
Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174PubMedCrossRef
31.
Ording Müller LS, Avenarius D, Olsen OE (2011) High signal in bone marrow at diffusion-weighted imaging with body background suppression (DWIBS) in healthy children. Pediatr Radiol 41:221–226PubMedCrossRef
32.
Nievelstein RA, Quarles van Ufford HM, Kwee TC et al (2012) Radiation exposure and mortality risk from CT and PET imaging of patients with malignant lymphoma. Eur Radiol 22:1946–1954PubMedCentralPubMedCrossRef
33.
Punwani S, Prakash V, Bainbridge A et al (2010) Quantitative diffusion weighted MRI: a functional biomarker of nodal disease in Hodgkin lymphoma? Cancer Biomark 7:249–259PubMed
34.
Wu X, Kellokumpu-Lehtinen PL, Pertovaara H et al (2011) Diffusion-weighted MRI in early chemotherapy response evaluation of patients with diffuse large B-cell lymphoma–a pilot study: comparison with 2-deoxy-2-fluoro- D-glucose-positron emission tomography/computed tomography. NMR Biomed 24:1181–1190PubMedCrossRef
35.
Punwani S, Taylor SA, Saad ZZ et al (2013) Diffusion-weighted MRI of lymphoma: prognostic utility and implications for PET/MRI? Eur J Nucl Med Mol Imaging 40:373–385PubMedCrossRef
Metadata
Title
Whole-body MRI for initial staging of paediatric lymphoma: prospective comparison to an FDG-PET/CT-based reference standard
Authors
Annemieke S. Littooij
Thomas C. Kwee
Ignasi Barber
Claudio Granata
Malou A. Vermoolen
Goya Enríquez
József Zsíros
Shui Yen Soh
Bart de Keizer
Frederik J. A. Beek
Monique G. Hobbelink
Marc B. Bierings
Jaap Stoker
Rutger A.J. Nievelstein
Publication date
01-05-2014
Publisher
Springer Berlin Heidelberg
Published in
European Radiology / Issue 5/2014
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-014-3114-0

Other articles of this Issue 5/2014

European Radiology 5/2014 Go to the issue

Urogenital

Routinely performed multiparametric magnetic resonance imaging helps to differentiate common subtypes of renal tumours

Hepatobiliary-Pancreas

Relapse of IgG4-related sclerosing cholangitis after steroid therapy: image findings and risk factors

Hepatobiliary-Pancreas

Hepatic cysts treated with percutaneous ethanol sclerotherapy: time to extend the indications to haemorrhagic cysts and polycystic liver disease

Contrast Media

The incidence of contrast-induced nephropathy (CIN) following transarterial chemoembolisation (TACE) in patients with hepatocellular carcinoma (HCC)

Interventional

Effectiveness of combined use of imprint cytological and histological examination in CT-guided tissue-core biopsy

Breast

Variations in screening outcome among pairs of screening radiologists at non-blinded double reading of screening mammograms: a population-based study